Among #Medicare beneficiaries, women undergoing #TAVI experienced higher periprocedural complications and mortality but modestly better long-term survival vs men, with their proportion among TAVI recipients declining over time. https://t.co/3G01MLCDdn
Among #Medicare beneficiaries, women undergoing #TAVI experienced higher periprocedural complications and mortality but modestly better long-term survival vs men, with their proportion among TAVI recipients declining over time. https://t.co/qkUmQyPbJT
✨ Excited to share our latest from the @MountSinaiNYC Cath Lab! In 19,651 real-world PCI patients: <1 in 3 had all 4 #SMuRFs controlled. More controlled risk factors = lower 1-yr MACE — with glycemic control being the most impactful (44%⬇️in MACE). https://t.co/7gGxRR5C0u
Among #Medicare beneficiaries, women undergoing #TAVI experienced higher periprocedural complications and mortality but modestly better long-term survival vs men, with their proportion among TAVI recipients declining over time. https://t.co/FJcCNb0KOM
Thrilled to share our paper out today in @JAMACardio work from my @NIH R38 research year with an incredible group of co-authors. In 314,000+ Medicare pts undergoing TAVI (2013–2022), we examined 10-year sex-based trends:
https://t.co/CDCdXVkLMH
Yet women carried a higher long-term burden of HF hospitalizations, stroke & bleeding. Better survival ≠ fewer complications. Sex-specific optimization of care remains essential as TAVI expands to younger, lower-risk patients.
Thrilled to welcome our new incoming Cardiology Fellows! 🎓❤️
Can’t wait to see the talent, curiosity, and compassion you’ll bring to the program.
Here’s to years of learning, teamwork, and advancing heart care together. #CardioTwitter#MedTwitter